Dabrafenib + Trametinib + PDR001 In Colorectal Cancer

Clinical trial NCT03668431 · UNKNOWN

Trial details

NCT number: NCT03668431
Sponsor: Massachusetts General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2018-10-15
Primary completion: 2022-09-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.